SCHEMBL7655847

SCHEMBL7655847

O=S(=O)(Cc1cc(F)cc(F)c1)NC1CN(C(c2ccc(Cl)cc2)c2cccnc2)C1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 10/20 0.48
CYP3A5 P20815 10/20 0.48
FNTA P49354 1/20 0.39
FNTB P49356 1/20 0.39
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
POLB P06746 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CYP19A1 P11511 1/20 0.36
NPSR1 Q6W5P4 1/20 0.35
SLC1A3 P43003 1/20 0.35
SLC1A2 P43004 1/20 0.35
SLC1A1 P43005 1/20 0.35
TBXA2R P21731 1/20 0.35
TBXAS1 P24557 1/20 0.35
USP2 O75604 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2910952 0.86 CYP3A4 (0.51) CYP3A4CYP3A5KDM4EALDH1A1POLB
SCHEMBL3294234 0.84 CYP3A4 (0.49) CYP3A4CYP3A5FNTAFNTBKDM4E
SCHEMBL2909234 0.78 SLC6A9 (0.42) CYP3A4HTTTBXA2RUSP2
SCHEMBL4027883 0.76 CYP3A4 (0.56) CYP3A4CYP3A5FNTAFNTBKDM4E
SCHEMBL2905660 0.75 CYP3A4 (0.54) CYP3A4CYP3A5FNTAFNTBCYP19A1
SCHEMBL2905664 0.75 CYP3A4 (0.54) CYP3A4CYP3A5FNTAFNTBCYP19A1
SCHEMBL2906358 0.75 CYP3A4 (0.54) CYP3A4CYP3A5FNTAFNTBCYP19A1
SCHEMBL2906185 0.75 CYP3A4 (0.53) CYP3A4CYP3A5FNTAFNTBKDM4E
SCHEMBL2909216 0.75 CYP3A4 (0.38) CYP3A4CYP3A5HTTCYP19A1
SCHEMBL2911655 0.73 KMT2A (0.39) HTTCYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6355631-B1 TREATMENT OF PSYCHOSIS AND SCHIZOPHRENIA AVENTIS PHARMA S.A. (FR) 2002-03-12 US disclosed